Changes in Board and Committee Composition SHANGHAI, Nov. 22, 2024 /PRNewswire/ — Lufax Holding Ltd ("Lufax" or the… CISION PRNewswireNovember 22, 2024
Bright Scholar Schedules Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024 Ended August 31, 2024 CAMBRIDGE, England and FOSHAN, China, Nov. 22, 2024 /PRNewswire/ — Bright Scholar Education Holdings… CISION PRNewswireNovember 22, 2024
Electricity sales in the Aksu region reached the 20 billion mark 35 days ahead of schedule AKSU, China, Nov. 22, 2024 /PRNewswire/ — According to the latest statistics,… CISION PRNewswireNovember 22, 2024
Press ReleaseTechChongtai Yangtze River Tunnel: A Successful Trial of China's Intelligent Shield Tunneling Technology SHANGHAI, Nov. 22, 2024 /PRNewswire/ — China’s latest intelligent shield tunneling technology… CISION PRNewswireNovember 22, 2024
China Matters' Feature: How High-Quality Development Is Shaping China's Future BEIJING, Nov. 22, 2024 /PRNewswire/ — China has entered a transformative phase… CISION PRNewswireNovember 22, 2024
LONGi advocates for accelerating the energy just transition through green innovation at COP29 BAKU, Azerbaijan, Nov. 22, 2024 /PRNewswire/ — On November 11th, the 29th… CISION PRNewswireNovember 22, 2024
Press ReleaseSTATION Ai, Japan's Largest Open Innovation Hub, Celebrates Grand Opening and Holds "IGNITION" Themed Events STATION Ai, Japan’s largest open innovation hub, officially launched with a grand… CISION PRNewswireNovember 22, 2024
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer NANJING, China, Nov. 22, 2024 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd.… CISION PRNewswireNovember 22, 2024
